Total Payments
$15,727
2024 Payments
$964.61
Companies
56
Transactions
868
Medicare Patients
2,170
Medicare Billing
$317,291
Payment Breakdown by Category
Food & Beverage$15,593 (99.1%)
Education$74.65 (0.5%)
Gifts$59.40 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,593 | 861 | 99.1% |
| Education | $74.65 | 6 | 0.5% |
| Gift | $59.40 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,159 | 159 | $0 (2024) |
| Lilly USA, LLC | $1,656 | 94 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,251 | 63 | $0 (2024) |
| Novo Nordisk Inc | $888.93 | 53 | $0 (2024) |
| Mannkind Corporation | $811.03 | 57 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $740.08 | 36 | $0 (2024) |
| IBSA Pharma Inc. | $715.60 | 57 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $616.10 | 33 | $0 (2024) |
| ABBVIE INC. | $549.76 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $413.58 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $964.61 | 53 | Novartis Pharmaceuticals Corporation ($162.31) |
| 2023 | $1,276 | 72 | Novartis Pharmaceuticals Corporation ($169.60) |
| 2022 | $1,500 | 82 | Novartis Pharmaceuticals Corporation ($259.38) |
| 2021 | $1,894 | 105 | Amgen Inc. ($354.29) |
| 2020 | $2,156 | 113 | Amgen Inc. ($395.59) |
| 2019 | $2,572 | 143 | Amgen Inc. ($820.95) |
| 2018 | $2,361 | 139 | Amgen Inc. ($501.34) |
| 2017 | $3,002 | 161 | Amgen Inc. ($816.61) |
All Payment Transactions
868 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $1.48 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.76 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Oncology | ||||||
| 11/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $3.10 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: Endocrinology | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.51 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $4.90 | General |
| Category: Endocrinology | ||||||
| 09/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $4.36 | General |
| Category: Endocrinology | ||||||
| 09/05/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 09/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $39.83 | General |
| 08/14/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Endocrinology | ||||||
| 08/14/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $4.44 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: DIABETES | ||||||
| 07/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 567 | 1,703 | $213,417 | $96,054 |
| 2022 | 8 | 434 | 966 | $157,944 | $69,460 |
| 2021 | 8 | 500 | 1,044 | $153,329 | $73,533 |
| 2020 | 9 | 669 | 1,380 | $198,889 | $78,244 |
Total Patients
2,170
Total Services
5,093
Medicare Billing
$317,291
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 521 | $117,225 | $50,639 | 43.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 37 | 371 | $27,825 | $12,918 | 46.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 38 | 204 | $15,300 | $8,876 | 58.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 35 | 163 | $16,300 | $7,739 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 57 | $15,675 | $7,546 | 48.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 251 | $5,522 | $2,108 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $6,120 | $1,698 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $3,610 | $1,520 | 42.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 14 | $1,175 | $1,004 | 85.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 15 | 25 | $1,250 | $693.52 | 55.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 38 | 38 | $1,520 | $687.04 | 45.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 13 | $770.00 | $443.82 | 57.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $1,125 | $181.16 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 527 | $117,000 | $51,621 | 44.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 53 | 61 | $16,650 | $9,286 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 39 | $7,300 | $2,728 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $7,080 | $2,509 | 35.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 23 | $1,725 | $1,567 | 90.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 97 | 262 | $5,764 | $770.91 | 13.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $1,150 | $763.11 | 66.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $1,275 | $215.12 | 16.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 515 | $103,000 | $52,233 | 50.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 64 | $16,000 | $9,340 | 58.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 132 | $23,760 | $8,726 | 36.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 28 | 28 | $2,100 | $1,762 | 83.9% |
About Dr. Samuel Mayeda, MD
Dr. Samuel Mayeda, MD is a Specialist healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487716544.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Mayeda, MD has received a total of $15,727 in payments from pharmaceutical and medical device companies, with $964.61 received in 2024. These payments were reported across 868 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($15,593).
As a Medicare-enrolled provider, Mayeda has provided services to 2,170 Medicare beneficiaries, totaling 5,093 services with total Medicare billing of $317,291. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Orange, CA
- Active Since 12/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487716544
Products in Payments
- Repatha (Biological) $1,050
- AFREZZA (Drug) $811.03
- JARDIANCE (Drug) $804.62
- Prolia (Biological) $789.59
- Aimovig (Biological) $753.31
- Tirosint (Drug) $558.25
- TRULICITY (Drug) $423.21
- FARXIGA (Drug) $374.26
- LEQVIO (Drug) $372.29
- Saxenda (Drug) $334.09
- BAQSIMI (Drug) $309.11
- Ozempic (Drug) $307.23
- SOLIQUA (Drug) $305.64
- EVENITY (Biological) $297.14
- Omnipod (Device) $281.84
- TOUJEO (Drug) $269.24
- Livalo (Drug) $260.33
- SOLIQUA 100/33 (Biological) $255.46
- PRALUENT (Drug) $247.22
- NEXLETOL (Drug) $244.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Orange
Andrew Cassidenti, M.d, M.D
Specialist — Payments: $83,590
Specialist $83,590
Dr. Steve Mora, M.d, M.D
Specialist — Payments: $54,129
Specialist $54,129
Dr. Brian Palafox, M.d, M.D
Specialist — Payments: $53,229
Specialist $53,229
Dr. Samuel Rosenfeld, M.d, M.D
Specialist — Payments: $47,823
Specialist $47,823
Dr. Thomas Kim, M.d, M.D
Specialist — Payments: $47,716
Specialist $47,716
Gerald Alexander, M.d, M.D
Specialist — Payments: $45,760
Specialist $45,760